The role of Ryk and Ror receptor tyrosine kinases in wnt signal transduction

Cold Spring Harbor Perspectives in Biology

Volumn 6, Issue 2, 2014, Pages

  Green, Jennifer ^a,c   Nusse, Roel ^a   van Amerongen, Renée ^b  

^a STANFORD UNIVERSITY   (United States)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c ACTIVX BIOSCIENCES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR; ROR1 PROTEIN, MOUSE; ROR2 PROTEIN, MOUSE; RYK PROTEIN, MOUSE; WNT PROTEIN;

ANIMAL; ARTICLE; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL MOVEMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MICE; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTORS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84893223752     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a009175     Document Type: Article

References (132)

1. Afzal AR, Jeffery S. 2003. One gene, two phenotypes: ROR2 mutations in autosomal recessive Robinow syndrome and autosomal dominant brachydactyly type B. Hum Mutat 22: 1-11.
2. Afzal AR, Rajab A, Fenske CD, Oldridge M, Elanko N, Ternes-Pereira E, Tuysuz B, Murday VA, Patton MA, Wilkie AO, et al. 2000. Recessive Robinow syndrome, allelic to dominant brachydactyly type B, is caused by mutation of ROR2. Nat Genet 25: 419-422.
3. Akbarzadeh S, Wheldon LM, Sweet SM, Talma S, Mardakheh FK, Heath JK. 2008. The deleted in brachydactyly B domain of ROR2 is required for receptor activation by recruitment of Src. PLoS ONE 3: e1873.
4. Al-Shawi R, Ashton SV, Underwood C, Simons JP. 2001. Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development. Dev Genes Evol 211: 161-171.
5. Andre P, Wang Q, Wang N, Gao B, Schilit A, Halford MM, Stacker SA, Zhang X, Yang Y. 2012. The Wnt coreceptor Ryk regulates Wnt/planar cell polarity by modulating the degradation of the core planar cell polarity component Vangl2. J Biol Chem 287: 44518-44525.
6. Angers S, Moon RT. 2009. Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol 10: 468-477.
7. Barna G, Mihalik R, Timar B, Tombol J, Csende Z, Sebestyen A, Bodor C, Csernus B, Reiniger L, Petak I, et al. 2011. ROR1 expression is not a unique marker of CLL. Hematol Oncol 29: 17-21.
8. Baskar S, Kwong KY, Hofer T, Levy JM, Kennedy MG, Lee E, Staudt LM, Wilson WH, Wiestner A, Rader C. 2008. Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia. Clin Cancer Res 14: 396-404.
9. Baskar S, Wiestner A, Wilson WH, Pastan I, Rader C. 2012. Targeting malignant B cellswith an immunotoxin against ROR1. MAbs 4: 349-361.
10. Berndt JD, Aoyagi A, Yang P, Anastas JN, Tang L, Moon RT. 2011. Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. J Cell Biol 194: 737-750.
11. Bhanot P, Brink M, Samos CH, Hsieh JC, Wang Y, Macke JP, Andrew D, Nathans J, Nusse R. 1996. A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 382: 225-230.
12. Bicocca VT, Chang BH, Masouleh BK, Muschen M, Loriaux MM, Druker BJ, Tyner JW. 2012. Crosstalk betweenROR1 and the Pre-B cell receptor promotes survival of t(1;19) acute lymphoblastic leukemia. Cancer Cell 22: 656-667.
13. Billiard J, Way DS, Seestaller-Wehr LM, Moran RA, Mangine A, Bodine PV. 2005. The orphan receptor tyrosine kinase Ror2 modulates canonical Wnt signaling in osteoblastic cells. Mol Endocrinol 19: 90-101.
14. Bonkowsky JL, Yoshikawa S, O'Keefe DD, Scully AL, Thomas JB. 1999. Axon routing across the midline controlled by the Drosophila Derailed receptor. Nature 402: 540-544.
15. Callahan CA, Muralidhar MG, Lundgren SE, Scully AL, Thomas JB. 1995. Control of neuronal pathway selection by a Drosophila receptor protein-tyrosine kinase family member. Nature 376: 171-174.
16. Callahan CA, Bonkovsky JL, Scully AL, Thomas JB. 1996. Derailed is required for muscle attachment site selection in Drosophila. Development 122: 2761-2767.
17. Carmon KS, Loose DS. 2010. Development of a bioassay for detection of Wnt-binding affinities for individual frizzled receptors. Anal Biochem 401: 288-294.
18. Chen W, ten Berge D, Brown J, Ahn S, Hu LA, Miller WE, Caron MG, Barak LS, Nusse R, Lefkowitz RJ. 2003. Dishevelled 2 recruits b-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4. Science 301: 1391-1394.
19. Choudhury A, Derkow K, Daneshmanesh AH, Mikaelsson E, Kiaii S, Kokhaei P, Osterborg A, Mellstedt H. 2010. Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells. Br J Haematol 151: 327-335.
20. Clevers H, Nusse R. 2012. Wnt/β-catenin signaling and disease. Cell 149: 1192-1205.
21. Daneshmanesh AH, Mikaelsson E, Jeddi-Tehrani M, Bayat AA, Ghods R, Ostadkarampour M, Akhondi M, Lagercrantz S, Larsson C, Osterborg A, et al. 2008. Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy. Int J Cancer 123: 1190-1195.
22. Daneshmanesh AH, Hojjat-Farsangi M, Khan AS, Jeddi-Tehrani M, Akhondi MM, Bayat AA, Ghods R, Mahmoudi AR, Hadavi R, Osterborg A, et al. 2012. Monoclonal antibodies against ROR1 induce apoptosis of chronic lymphocytic leukemia (CLL) cells. Leukemia 26: 1348-1355.
23. Dave H, Anver MR, Butcher DO, Brown P, Khan J, Wayne AS, Baskar S, Rader C. 2012. Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric Blineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodies. PLoS ONE 7: e52655.
24. Davidson G, Wu W, Shen J, Bilic J, Fenger U, Stannek P, Glinka A, Niehrs C. 2005. Casein kinase 1 g couples Wnt receptor activation to cytoplasmic signal transduction. Nature 438: 867-872.
25. DeChiara TM, Kimble RB, Poueymirou WT, Rojas J, Masiakowski P, Valenzuela DM, Yancopoulos GD. 2000. Ror2, encoding a receptor-like tyrosine kinase, is required for cartilage and growth plate development. Nat Genet 24: 271-274.
26. Edris B, Espinosa I, Muhlenberg T, Mikels A, Lee CH, Steigen SE, Zhu S, Montgomery KD, Lazar AJ, Lev D, et al. 2012. ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour. J Pathol 227: 223-233.
27. Endo M, Doi R, Nishita M, Minami Y. 2012. Ror family receptor tyrosine kinases regulate the maintenance of neural progenitor cells in the developing neocortex. J Cell Sci 125: 2017-2029.
28. Enomoto M, Hayakawa S, Itsukushima S, Ren DY, Matsuo M, Tamada K, Oneyama C, Okada M, Takumi T, Nishita M, et al. 2009. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling. Oncogene 28: 3197-3208.
29. Fiedler M, Mendoza-Topaz C, Rutherford TJ, Mieszczanek J, Bienz M. 2011. Dishevelled interacts with the DIX domain polymerization interface of Axin to interfere with its function in down-regulating β-catenin. Proc Natl Acad Sci 108: 1937-1942.
30. Forrester WC, Dell M, Perens E, Garriga G. 1999. AC. elegans Ror receptor tyrosine kinase regulates cell motility and asymmetric cell division. Nature 400: 881-885.
31. Forrester WC, Kim C, Garriga G. 2004. The Caenorhabditis elegans Ror RTKCAM-1 inhibits EGL-20/Wnt signaling in cell migration. Genetics 168: 1951-1962.
32. Fradkin LG, Noordermeer JN, Nusse R. 1995. The Drosophila Wnt protein DWnt-3 is a secreted glycoprotein localized on the axon tracts of the embryonic CNS. Dev Biol 168: 202-213.
33. Fradkin LG, van Schie M, Wouda RR, de Jong A, Kamphorst JT, Radjkoemar-Bansraj M, Noordermeer JN. 2004. The Drosophila Wnt5 protein mediates selective axon fasciculation in the embryonic central nervous system. Dev Biol 272: 362-375.
34. Fradkin LG, Dura JM, Noordermeer JN. 2010. Ryks: New partners for Wnts in the developing and regenerating nervous system. Trends Neurosci 33: 84-92.
35. Francis MM, Evans SP, Jensen M, Madsen DM, Mancuso J, Norman KR, Maricq AV. 2005. The Ror receptor tyrosine kinase CAM-1 is required for ACR-16-mediated synaptic transmission at the C. elegans neuromuscular junction. Neuron 46: 581-594.
36. Fukuda T, Chen L, Endo T, Tang L, Lu D, Castro JE, Widhopf GF 2nd, Rassenti LZ, Cantwell MJ, Prussak CE, et al. 2008. Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a. Proc Natl Acad Sci 105: 3047-3052.
37. Gentile A, Lazzari L, Benvenuti S, Trusolino L, Comoglio PM. 2011. Ror1 is a pseudokinase that is crucial for Metdriven tumorigenesis. Cancer Res 71: 3132-3141.
38. Green JL, Inoue T, Sternberg PW. 2007. The C. elegans ROR receptor tyrosine kinase, CAM-1, non-autonomously inhibits the Wnt pathway. Development 134: 4053-4062.
39. Green JL, Inoue T, Sternberg PW. 2008a. Opposing Wnt pathways orient cell polarity during organogenesis. Cell 134: 646-656.
40. Green JL, Kuntz SG, Sternberg PW. 2008b. Ror receptor tyrosine kinases: Orphans no more. Trends Cell Biol 18: 536-544.
41. Grossmann AH, Yoo JH, Clancy J, Sorensen LK, Sedgwick A, Tong Z, Ostanin K, Rogers A, Grossmann KF, Tripp SR, et al. 2013. The small GTPase ARF6 stimulates β-catenin transcriptional activity during WNT5A-mediated melanoma invasion and metastasis. Sci Signal 6: pra14.
42. Grumolato L, Liu G, Mong P, Mudbhary R, Biswas R, Arroyave R, Vijayakumar S, Economides AN, Aaronson SA. 2010. Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev 24: 2517-2530.
43. Halford MM, Oates AC, Hibbs ML, Wilks AF, Stacker SA. 1999. Genomic structure and expression of the mouse growth factor receptor related to tyrosine kinases (Ryk). J Biol Chem 274: 7379-7390.
44. Hayashi Y, Hirotsu T, Iwata R, Kage-Nakadai E, Kunitomo H, Ishihara T, Iino Y, Kubo T. 2009. A trophic role for Wnt-Ror kinase signaling during developmental pruning in Caenorhabditis elegans. Nat Neurosci 12: 981-987.
45. He X, Semenov M, Tamai K, Zeng X. 2004. LDL receptorrelated proteins 5 and 6 in Wnt/β-catenin signaling: Arrows point the way. Development 131: 1663-1677.
46. Hikasa H, Shibata M, Hiratani I, Taira M. 2002. The Xenopus receptor tyrosine kinase Xror2 modulates morphogenetic movements of the axial mesoderm and neuroectoderm via Wnt signaling. Development 129: 5227-5239.
47. Ho HY, Susman MW, Bikoff JB, Ryu YK, Jonas AM, Hu L, Kuruvilla R, Greenberg ME. 2012. Wnt5a-Ror-Dishevelled signaling constitutes a core developmental pathway that controls tissue morphogenesis. Proc Natl Acad Sci 109: 4044-4051.
48. Hsieh JC, Kodjabachian L, Rebbert ML, Rattner A, Smallwood PM, Samos CH, Nusse R, Dawid IB, Nathans J. 1999a. A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 398: 431-436.
49. Hsieh JC, Rattner A, Smallwood PM, Nathans J. 1999b. Biochemical characterization of Wnt-frizzled interactions using a soluble, biologically active vertebrate Wnt protein. Proc Natl Acad Sci 96: 3546-3551.
50. Hudecek M, Schmitt TM, Baskar S, Lupo-Stanghellini MT, Nishida T, Yamamoto TN, Bleakley M, Turtle CJ, Chang WC, Greisman HA, et al. 2010. The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor. Blood 116: 4532-4541.
51. Inoue T, Oz HS, Wiland D, Gharib S, Deshpande R, Hill RJ, Katz WS, Sternberg PW. 2004. C. elegans LIN-18 is a Ryk ortholog and functions in parallel to LIN-17/Frizzled in Wnt signaling. Cell 118: 795-806.
52. 2+ pathway to antagonize Wnt/β-catenin signaling. Mol Cell Biol 23: 131-139.
53. Janda CY, Waghray D, Levin AM, Thomas C, Garcia KC. 2012. Structural basis of Wnt recognition by Frizzled. Science 337: 59-64.
54. Kani S, Oishi I, Yamamoto H, Yoda A, Suzuki H, Nomachi A, Iozumi K, Nishita M, Kikuchi A, Takumi T, et al. 2004. The receptor tyrosine kinase Ror2 associates with and is activated by casein kinase Ie. J Biol Chem 279: 50102-50109.
55. Keeble TR, Cooper HM. 2006. Ryk: A novel Wnt receptor regulating axon pathfinding. Int J Biochem Cell Biol 38: 2011-2017.
56. Kennerdell JR, Fetter RD, Bargmann CI. 2009. Wnt-Ror signaling to SIA and SIB neurons directs anterior axon guidance and nerve ring placement in C. elegans. Development 136: 3801-3810.
57. Kim GH, Her JH, Han JK. 2008. Ryk cooperates with Frizzled 7 to promote Wnt11-mediated endocytosis and is essential for Xenopus laevis convergent extension movements. J Cell Biol 182: 1073-1082.
58. Lahaye LL, Wouda RR, de Jong AW, Fradkin LG, Noordermeer JN. 2012. WNT5 interacts with the Ryk receptors doughnut and derailed to mediate muscle attachment site selection in Drosophila melanogaster. PLoS ONE 7: e32297.
59. Lara E, Calvanese V, Huidobro C, Fernandez AF, Moncada-Pazos A, Obaya AJ, Aguilera O, Gonzalez-Sancho JM, Sanchez L, Astudillo A, et al. 2010. Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer. Mol Cancer 9: 170.
60. Li C, Chen H, Hu L, Xing Y, Sasaki T, Villosis MF, Li J, Nishita M, Minami Y, Minoo P. 2008. Ror2 modulates the canonical Wnt signaling in lung epithelial cells through cooperation with Fzd2. BMC Mol Biol 9: 11.
61. Li P, Harris D, Liu Z, Liu J, Keating M, Estrov Z. 2010. Stat3 activates the receptor tyrosine kinase like orphan receptor-1 gene in chronic lymphocytic leukemia cells. PLoS ONE 5: e11859.
62. Lin S, Baye LM, Westfall TA, Slusarski DC. 2010. Wnt5b-Ryk pathway provides directional signals to regulate gastrulation movement. J Cell Biol 190: 263-278.
63. Liu Y, Ross JF, Bodine PV, Billiard J. 2007. Homodimerization of Ror2 tyrosine kinase receptor induces 14-3-3(b) phosphorylation and promotes osteoblast differentiation and bone formation. Mol Endocrinol 21: 3050-3061.
64. Liu Y, Rubin B, Bodine PV, Billiard J. 2008. Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase. J Cell Biochem 105: 497-502.
65. Lu W, Yamamoto V, Ortega B, Baltimore D. 2004a. Mammalian Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth. Cell 119: 97-108.
66. Lu X, Borchers AG, Jolicoeur C, Rayburn H, Baker JC, Tessier-Lavigne M. 2004b. PTK7/CCK-4 is a novel regulator of planar cell polarity in vertebrates. Nature 430: 93-98.
67. Lyashenko N, Weissenbock M, Sharir A, Erben RG, Minami Y, Hartmann C. 2010. Mice lacking the orphan receptor ror1 have distinct skeletal abnormalities and are growth retarded. Dev Dyn 239: 2266-2277.
68. Lyu J, Yamamoto V, Lu W. 2008. Cleavage of the Wnt receptor Ryk regulates neuronal differentiation during cortical neurogenesis. Dev Cell 15: 773-780.
69. Lyu J, Wesselschmidt RL, Lu W. 2009. Cdc37 regulates Ryk signaling by stabilizing the cleaved Ryk intracellular domain. J Biol Chem 284: 12940-12948.
70. Macheda ML, Sun WW, Kugathasan K, Hogan BM, Bower NI, Halford MM, Zhang YF, Jacques BE, Lieschke GJ, Dabdoub A, et al. 2012. The Wnt receptor Ryk plays a role in mammalian planar cell polarity signaling. J Biol Chem 287: 29312-29323.
71. MacKeigan JP, Murphy LO, Blenis J. 2005. Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat Cell Biol 7: 591-600.
72. Makino K, Goto Y, Sueyasu M, Futagami K, Kataoka Y, Oishi R. 1997. Micellar electrokinetic capillary chromatography for therapeutic drug monitoring of zonisamide. J Chromatogr B Biomed Sci Appl 695: 417-425.
73. Malinauskas T, Aricescu AR, Lu W, Siebold C, Jones EY. 2011. Modular mechanismof Wnt signaling inhibition by Wnt inhibitory factor 1. Nat Struct Mol Biol 18: 886-893.
74. Mao J, Wang J, Liu B, Pan W, Farr GH, Flynn C, Yuan H, Takada S, Kimelman D, Li L, et al. 2001. Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Mol Cell 7: 801-809.
75. Masiakowski P, Carroll RD. 1992. A novel family of cell surface receptors with tyrosine kinase-like domain. J Biol Chem 267: 26181-26190.
76. Matsuda T, Nomi M, Ikeya M, Kani S, Oishi I, Terashima T, Takada S, Minami Y. 2001. Expression of the receptor tyrosine kinase genes, Ror1 and Ror2, during mouse development. Mech Dev 105: 153-156.
77. Matsuda T, Suzuki H, Oishi I, Kani S, Kuroda Y, Komori T, Sasaki A, Watanabe K, Minami Y. 2003. The receptor tyrosine kinase Ror2 associates with the melanoma-associated antigen (MAGE) family protein Dlxin-1 and regulates its intracellular distribution. J Biol Chem 278: 29057-29064.
78. Mikels AJ, Nusse R. 2006. Purified Wnt5a protein activates or inhibits β-catenin-TCF signaling depending on receptor context. PLoS Biol 4: e115.
79. Mikels A, Minami Y, Nusse R. 2009. Ror2 receptor requires tyrosine kinase activity to mediate Wnt5A signaling. J Biol Chem 284: 30167-30176.
80. Morioka K, Tanikawa C, Ochi K, Daigo Y, Katagiri T, Kawano H, Kawaguchi H, Myoui A, Yoshikawa H, Naka N, et al. 2009. Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma. Cancer Sci 100: 1227-1233.
81. Nishita M, Yoo SK, Nomachi A, Kani S, Sougawa N, Ohta Y, Takada S, Kikuchi A, Minami Y. 2006. Filopodia formation mediated by receptor tyrosine kinase Ror2 is required for Wnt5a-induced cell migration. J Cell Biol 175: 555-562.
82. Nishita M, Itsukushima S, Nomachi A, Endo M, Wang Z, Inaba D, Qiao S, Takada S, Kikuchi A, Minami Y. 2010. Ror2/Frizzled complex mediates Wnt5a-induced AP-1 activation by regulating Dishevelled polymerization. Mol Cell Biol 30: 3610-3619.
83. Nomachi A, Nishita M, Inaba D, Enomoto M, Hamasaki M, Minami Y. 2008. Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding protein filamin A. J Biol Chem 283: 27973-27981.
84. Nomi M, Oishi I, Kani S, Suzuki H, Matsuda T, Yoda A, Kitamura M, Itoh K, Takeuchi S, Takeda K, et al. 2001. Loss of mRor1 enhances the heart and skeletal abnormalities in mRor2-deficient mice: Redundant and pleiotropic functions of mRor1 and mRor2 receptor tyrosine kinases. Mol Cell Biol 21: 8329-8335.
85. O'Connell MP, Fiori JL, Baugher KM, Indig FE, French AD, Camilli TC, Frank BP, Earley R, Hoek KS, Hasskamp JH, et al. 2009. Wnt5A activates the calpain-mediated cleavage of filamin A. J Invest Dermatol 129: 1782-1789.
86. O'Connell MP, Fiori JL, Xu M, Carter AD, Frank BP, Camilli TC, French AD, Dissanayake SK, Indig FE, Bernier M, et al. 2010. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. Oncogene 29: 34-44.
87. Oishi I, Takeuchi S, Hashimoto R, Nagabukuro A, Ueda T, Liu ZJ, Hatta T, Akira S, Matsuda Y, Yamamura H, et al. 1999. Spatio-temporally regulated expression of receptor tyrosine kinases, mRor1, mRor2, during mouse development: implications in development and function of the nervous system. Genes Cells 4: 41-56.
88. Oishi I, Suzuki H, Onishi N, Takada R, Kani S, Ohkawara B, Koshida I, Suzuki K, Yamada G, Schwabe GC, et al. 2003. The receptor tyrosine kinase Ror2 is involved in noncanonical Wnt5a/JNK signalling pathway. Genes Cells 8: 645-654.
89. Oldridge M, Fortuna AM, Maringa M, Propping P, Mansour S, Pollitt C, DeChiara TM, Kimble RB, Valenzuela DM, Yancopoulos GD, et al. 2000. Dominant mutations in ROR2, encoding an orphan receptor tyrosine kinase, cause brachydactyly type B. Nat Genet 24: 275-278.
90. Patthy L. 2000. The WIF module. Trends Biochem Sci 25: 12-13.
91. Peradziryi H, Kaplan NA, Podleschny M, Liu X, Wehner P, Borchers A, Tolwinski NS. 2011. PTK7/Otk interacts with Wnts and inhibits canonical Wnt signalling. EMBO J 30: 3729-3740.
92. Person AD, Beiraghi S, Sieben CM, Hermanson S, Neumann AN, Robu ME, Schleiffarth JR, Billington CJ Jr, van Bokhoven H, Hoogeboom JM, et al. 2010. WNT5A mutations in patients with autosomal dominant Robinowsyndrome. Dev Dyn 239: 327-337.
93. Pinson KI, Brennan J, Monkley S, Avery BJ, Skarnes WC. 2000. An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 407: 535-538.
94. Reddy UR, Phatak S, Pleasure D. 1996. Human neural tissues express a truncated Ror1 receptor tyrosine kinase, lacking both extracellular and transmembrane domains. Oncogene 13: 1555-1559.
95. Sakurai M, Aoki T, Yoshikawa S, Santschi LA, Saito H, Endo K, Ishikawa K, Kimura K, Ito K, Thomas JB, et al. 2009. Differentially expressed Drl and Drl-2 play opposing roles in Wnt5 signaling during Drosophila olfactory system development. J Neurosci 29: 4972-4980.
96. Saldanha J, Singh J, Mahadevan D. 1998. Identification of a Frizzled-like cysteine rich domain in the extracellular region of developmental receptor tyrosine kinases. Protein Sci 7: 1632-1635.
97. Sammar M, Stricker S, Schwabe GC, Sieber C, Hartung A, Hanke M, Oishi I, Pohl J, Minami Y, Sebald W, et al. 2004. Modulation of GDF5/BRI-b signalling through interaction with the tyrosine kinase receptor Ror2. Genes Cells 9: 1227-1238.
98. Sanchez-Solana B, Laborda J, Baladron V. 2012. Mouse resistin modulates adipogenesis and glucose uptake in 3T3-L1 preadipocytes through the ROR1 receptor. Mol Endocrinol 26: 110-127.
99. Sato A, Yamamoto H, Sakane H, Koyama H, Kikuchi A. 2010. Wnt5a regulates distinct signalling pathways by binding to Frizzled2. EMBO J 29: 41-54.
100. Schambony A, Wedlich D. 2007. Wnt-5A/Ror2 regulate expression of XPAPC through an alternative noncanonical signaling pathway. Dev Cell 12: 779-792.
101. Schwarz-Romond T, Fiedler M, Shibata N, Butler PJ, Kikuchi A, Higuchi Y, Bienz M. 2007. The DIX domain of Dishevelled confers Wnt signaling by dynamic polymerization. Nat Struct Mol Biol 14: 484-492.
102. Song S, Zhang B, Sun H, Li X, Xiang Y, Liu Z, Huang X, Ding M. 2010. AWnt-Frz/Ror-Dsh pathway regulates neurite outgrowth in Caenorhabditis elegans. PLoS Genet 6.
103. Stacker SA, Hovens CM, Vitali A, Pritchard MA, Baker E, Sutherland GR, Wilks AF. 1993. Molecular cloning and chromosomal localisation of the human homologue of a receptor related to tyrosine kinases (RYK). Oncogene 8: 1347-1356.
104. Taillebourg E, Moreau-Fauvarque C, Delaval K, Dura JM. 2005. In vivo evidence for a regulatory role of the kinase activity of the linotte/derailed receptor tyrosine kinase, a Drosophila Ryk ortholog. Dev Genes Evol 215: 158-163.
105. Takeuchi S, Takeda K, Oishi I, Nomi M, Ikeya M, Itoh K, Tamura S, Ueda T, Hatta T, Otani H, et al. 2000. Mouse Ror2 receptor tyrosine kinase is required for the heart development and limb formation. Genes Cells 5: 71-78.
106. Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y, Hess F, Saint-Jeannet JP, He X. 2000. LDL-receptorrelated proteins in Wnt signal transduction. Nature 407: 530-535.
107. Tauriello DV, Jordens I, Kirchner K, Slootstra JW, Kruitwagen T, Bouwman BA, Noutsou M, Rudiger SG, Schwamborn K, Schambony A, et al. 2012. Wnt/β-catenin signaling requires interaction of the Dishevelled DEP domain and C terminus with a discontinuous motif in Frizzled. Proc Natl Acad Sci 109: E812-820.
108. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y. 2003. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent β-catenin degradation. J Cell Biol 162: 899-908.
109. Tseng HC, Lyu PC, Lin WC. 2010. Nuclear localization of orphan receptor protein kinase (Ror1) is mediated through the juxtamembrane domain. BMC Cell Biol 11: 48.
110. Tseng HC, Kao HW, Ho MR, Chen YR, Lin TW, Lyu PC, Lin WC. 2011. Cytoskeleton network and cellular migration modulated by nuclear-localized receptor tyrosine kinase ROR1. Anticancer Res 31: 4239-4249.
111. Tyner JW, Deininger MW, Loriaux MM, Chang BH, Gotlib JR, Willis SG, Erickson H, Kovacsovics T, O'Hare T, Heinrich MC, et al. 2009. RNAi screen for rapid therapeutic target identification in leukemia patients. Proc Natl Acad Sci 106: 8695-8700.
112. Verkaar F, Blankesteijn WM, Smits JF, Zaman GJ. 2010. b-Galactosidase enzyme fragment complementation for the measurement of Wnt/β-catenin signaling. FASEB J 24: 1205-1217.
113. Wang X, Sommer RJ. 2011. Antagonism of LIN-17/Frizzled and LIN-18/Ryk in nematode vulva induction reveals evolutionary alterations in core developmental pathways. PLoS Biol 9: e1001110.
114. Wehrli M, Dougan ST, Caldwell K, O'Keefe L, Schwartz S, Vaizel-Ohayon D, Schejter E, Tomlinson A, DiNardo S. 2000. Arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 407: 527-530.
115. Wilson C, Goberdhan DC, Steller H. 1993. Dror, a potential neurotrophic receptor gene, encodes a Drosophila homolog of the vertebrate Ror family of Trk-related receptor tyrosine kinases. Proc Natl Acad Sci 90: 7109-7113.
116. Wouda RR, Bansraj MR, de Jong AW, Noordermeer JN, Fradkin LG. 2008. Src family kinases are required for WNT5 signaling through the Derailed/RYK receptor in the Drosophila embryonic central nervous system. Development 135: 2277-2287.
117. Wright TM, Brannon AR, Gordan JD, Mikels AJ, Mitchell C, Chen S, Espinosa I, van de Rijn M, Pruthi R, Wallen E, et al. 2009. Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma. Oncogene 28: 2513-2523.
118. Yamada M, Udagawa J, Matsumoto A, Hashimoto R, Hatta T, Nishita M, Minami Y, Otani H. 2010. Ror2 is required for midgut elongation during mouse development. Dev Dyn 239: 941-953.
119. Yamagata K, Li X, Ikegaki S, Oneyama C, Okada M, Nishita M, Minami Y. 2012. Dissection of Wnt5a-Ror2 signaling leading to matrix metalloproteinase (MMP-13) expression. J Biol Chem 287: 1588-1599.
120. Yamaguchi TP, Bradley A, McMahon AP, Jones S. 1999. A Wnt5a pathway underlies outgrowth of multiple structures in the vertebrate embryo. Development 126: 1211-1223.
121. Yamaguchi T, Yanagisawa K, Sugiyama R, Hosono Y, Shimada Y, Arima C, Kato S, Tomida S, Suzuki M, Osada H, et al. 2012. NKX2-1/TITF1/TTF-1-induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma. Cancer Cell 21: 348-361.
122. Yamamoto H, Yoo SK, Nishita M, Kikuchi A, Minami Y. 2007. Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2. Genes Cells 12: 1215-1223.
123. Yamamoto S, Nishimura O, Misaki K, Nishita M, Minami Y, Yonemura S, Tarui H, Sasaki H. 2008. Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex. Dev Cell 15: 23-36.
124. Yamamoto H, Oue N, Sato A, Hasegawa Y, Yamamoto H, Matsubara A, Yasui W, Kikuchi A. 2010. Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase. Oncogene 29: 2036-2046.
125. Yamamoto Y, Takeshita H, Sawa H. 2011. Multiple Wnts redundantly control polarity orientation in Caenorhabditis elegans epithelial stem cells. PLoS Genet 7: e1002308.
126. Yang J, Baskar S, Kwong KY, Kennedy MG, Wiestner A, Rader C. 2011. Therapeutic potential and challenges of targeting receptor tyrosine kinase ROR1 with monoclonal antibodies in B-cell malignancies. PLoS ONE 6: e21018.
127. Yen WW, Williams M, Periasamy A, Conaway M, Burdsal C, Keller R, Lu X, Sutherland A. 2009. PTK7 is essential for polarized cell motility and convergent extension during mouse gastrulation. Development 136: 2039-2048.
128. Yoshikawa S, Bonkowsky JL, Kokel M, Shyn S, Thomas JB. 2001. The derailed guidance receptor does not require kinase activity in vivo. J Neurosci 21: RC119.
129. Yoshikawa S, McKinnon RD, Kokel M, Thomas JB. 2003. Wnt-mediated axon guidance via the Drosophila Derailed receptor. Nature 422: 583-588.
130. Zeng X, Tamai K, Doble B, Li S, Huang H, Habas R, Okamura H, Woodgett J, He X. 2005. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 438: 873-877.
131. Zhang S, Chen L, Cui B, Chuang HY, Yu J, Wang-Rodriguez J, Tang L, Chen G, Basak GW, Kipps TJ. 2012. ROR1 is expressed in human breast cancer and associated with enhanced tumor-cell growth. PLoS ONE 7: e31127.
132. Zinovyeva AY, Yamamoto Y, Sawa H, Forrester WC. 2008. Complex network of Wnt signaling regulates neuronal migrations during Caenorhabditis elegans development. Genetics 179: 1357-1371.